Providing novel possibilities for all life.

After graduating from Waseda University in 2020, engaged in the investment banking business at the US investment bank, Houlihan Lokey.
In 2021, he co-founded Dioseve Inc. and became CEO of the company.

Worked as a researcher and associate professor at the Kyushu University School of Medicine from 2015 to 2020. Currently serving as HHMI Special Researcher at the University of Washington in the USA.
In 2021 he co-founded Dioseve Inc. and became the Chief Scientific Officer of the company.

Obtained a Doctorate degree from Azabu University, and worked as a researcher at the Child Health Institute of New Jersey, Shiga University of Medical Science, and University of Pennsylvania.
Joined Dioseve in 2023

Graduated from Universiti Kuala Lumpur Royal College of Medicine Perak in 2014 and engaged in research at Kyushu University’s Hayashi Laboratory.
Joined Dioseve as Senior Scientist in 2021.

Obtained a Doctorate degree from the faculty of medicine, Osaka University in 2012 and worked at Edinburg University as a post-doctoral fellow. In 2020 engaged in Kobayashi Pharmaceutical Co., Ltd.
Joined Dioseve as Senior Scientist in 2022

Obtained a Doctorate degree from the Graduate School of Agricultural and Life Sciences, The University of Tokyo in 2018 and worked as a pharmacologist in Astellas Pharma Inc.
Joined Dioseve as Senior Scientist in 2023

Obtained Doctorate degree from the School of Biomedical Sciences, the University of Hong Kong in 2021 and continued to work as a post-doctoral fellow in Cheah’s Lab from the same school.
Joined Dioseve in 2022.

Engaged in Sanwa Kagaku Kenkyusho as a Technician in 2013.
Academic Researcher at Kumamoto University in 2019.
Joined Dioseve in 2022.

Obtained a Doctorate degree from Yokohama City University, and worked as researcher at the National Center for Child Health and the Central Institute for Experimental Animals.
Joined Dioseve in 2022.

Graduated from the Department of Life and Environmental System Science, Yokohama City University in 2015. Finished Ph.D. program, Graduate School of Medicine, Kyoto University in 2020.
Work as a researcher at Peptidream Inc in 2021.
Joined Dioseve in 2023.

Obtained a Doctorate degree from the Graduate School of Chemical Sciences and Engineering, Hokkaido University in 2019. Worked at Niigata University and Hokkaido University as a specially-appointed assistant professor.
Joined Dioseve in 2023.

Graduated from Keio University School of Medicine and obtained a Doctorate degree from Kyushu University’s Hayashi Laboratory.
Joined Dioseve in 2022.

Obtained master’s degree in Animal Reproductive Science at Graduate School of Agricultural Science, Tohoku University in 2021. After graduation, he worked as an SE at Fujitsu Inc.
Joined Dioseve in 2023.

Graduated from the Department of Biopharmaceuticals, Kyoto Pharmaceutical University.
Launched the Clinical Development Department at Eli Lilly Japan and Parexel International, and since 2015, General Manager of JConsulting Management Department.

Professor Emeritus of Kyoto Univ. since 2018. Graduated from the Graduate School of Medicine, School of Medicine, Nagoya University. Director of Japan Society of Fertilization and Implantation. Director of Japan Society of Assisted Reproduction.
Board Chairman of Japan Society for
Uterus Transplantation.